Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
19 participants
OBSERVATIONAL
2014-02-28
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
NCT01104220
Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance
NCT04708535
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
NCT04232566
Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema
NCT03271034
Prospective Study of Functional and Quality of Life Outcomes in Panniculectomy Patients
NCT01464658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Weight (BMI: 18.5-24.9 kg/m²)
Liposuction/lipectomy
Liposuction/lipectomy
Subcutaneous adipose tissue will be obtained from liposuction/lipectomy to determine the types of immune cells
Overweight (BMI: 25.0-29.9 kg/m²)
Liposuction/lipectomy
Liposuction/lipectomy
Subcutaneous adipose tissue will be obtained from liposuction/lipectomy to determine the types of immune cells
Obese (BMI: >30.0kg/m²)
Liposuction/lipectomy
Liposuction/lipectomy
Subcutaneous adipose tissue will be obtained from liposuction/lipectomy to determine the types of immune cells
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liposuction/lipectomy
Subcutaneous adipose tissue will be obtained from liposuction/lipectomy to determine the types of immune cells
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 65 years
* Body Mass Index (BMI) ≥ 18.5 kg/m²
* Weight stable (+/- 3% during the last 2 months before enrollment)
* Women already scheduled for above mentioned procedures
Exclusion Criteria
* Recent (\<5 years) history of cancer (except in situ ductal breast carcinoma)
* Chemotherapy and/or radiation therapy within 4 months before enrollment
* Immune system diseases (i.e., autoimmune disorders, acquired immunodeficiency syndrome)
* Pregnant or breastfeeding
* Take any medication that might affect immune function
* Severe organ dysfunction
* BMI \<18.5 kg/m² or size of each breast is \>600 grams, if scheduled for bilateral breast reconstruction
18 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samuel Klein, MD
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-02113
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.